Nieke Vanavermaete
Knowledge Lawyer – Brussels
+32 2 780 2304
Posts by: Nieke Vanavermaete
- EMA advises study sponsors to amend Informed Consent Forms
- EU - Parallel Trade: restrictions and export bans for pharmaceuticals
- EU Court says off-label treatments must not be considered when assessing the significant benefit criterion in orphan drugs
- Belgium: Covid-19 coronavirus: measures to combat medicine shortages extended again
- Belgium - Covid-19 coronavirus: using saliva samples to detect SARS-CoV-2 as an alternative to sampling via a deep nasal swab?
- EU: Derogation for Covid-19 clinical trials of medicinal products containing or consisting of genetically modified organisms
- Belgium: Covid-19 – Coronavirus: updated guidance on managing clinical trials during pandemic
- Belgium: Covid-19 – Coronavirus: new guideline for management of clinical investigations for medical devices during pandemic
- Covid-19 coronavirus: Measures affecting the Belgium life sciences sector
- Covid-19 coronavirus: New guidance on managing clinical trials in Belgium
- EU data protection guidance on Covid-19 apps
- Belgium - New Bill on allowing access to confidential agreements between government and pharmaceutical companies
- EMA takes specific steps to reduce possible impact of Covid-19 on pharmaceutical supply chain in EU